Monoclonal B-cell lymphocytosis (MBL) is a recently defined medical condition that displays biological similarities to chronic lymphocytic leukemia (CLL), the most common subtype of adult leukemia in the Western world. MBL may be diagnosed in individuals with a normal lymphocyte count via a screening assay (screening MBL) or through the clinical evaluation of lymphocytosis (clinical MBL). Clinical MBL, which resembles CLL with a good prognosis, has attracted considerable interest because of its clinical and biological implications. The biological profile of clinical MBL appears indistinguishable from that of CLL for a large variety of markers. Differential diagnosis between clinical MBL and CLL is mainly based on peripheral blood B-cell counts. The 2008 International Workshop on Chronic Lymphocytic Leukemia (IWCLL) criteria changed the definition of CLL to a B-cell count ≥5.0 × 109/L to eliminate overlap between CLL and MBL. However, this cut-off is arbitrary, and recent studies suggest that a B-cell count of 10.0-11.0 × 109/L may represent the threshold that best predicts time to first treatment. After a diagnosis of clinical MBL, patients should be educated about appropriate monitoring and follow-up keeping in mind that, with time and counseling, most patients will understand that clinical MBL and CLL represent a continuum. © 2012 Informa UK, Ltd.

Monoclonal B-cell lymphocytosis: A reappraisal of its clinical implications / Stefano, Molica; Mauro, Francesca Romana; Matteo, Molica; DEL GIUDICE, Ilaria; Foa, Roberto. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - 53:9(2012), pp. 1660-1665. [10.3109/10428194.2012.666542]

Monoclonal B-cell lymphocytosis: A reappraisal of its clinical implications

MAURO, Francesca Romana;DEL GIUDICE, ILARIA;FOA, Roberto
2012

Abstract

Monoclonal B-cell lymphocytosis (MBL) is a recently defined medical condition that displays biological similarities to chronic lymphocytic leukemia (CLL), the most common subtype of adult leukemia in the Western world. MBL may be diagnosed in individuals with a normal lymphocyte count via a screening assay (screening MBL) or through the clinical evaluation of lymphocytosis (clinical MBL). Clinical MBL, which resembles CLL with a good prognosis, has attracted considerable interest because of its clinical and biological implications. The biological profile of clinical MBL appears indistinguishable from that of CLL for a large variety of markers. Differential diagnosis between clinical MBL and CLL is mainly based on peripheral blood B-cell counts. The 2008 International Workshop on Chronic Lymphocytic Leukemia (IWCLL) criteria changed the definition of CLL to a B-cell count ≥5.0 × 109/L to eliminate overlap between CLL and MBL. However, this cut-off is arbitrary, and recent studies suggest that a B-cell count of 10.0-11.0 × 109/L may represent the threshold that best predicts time to first treatment. After a diagnosis of clinical MBL, patients should be educated about appropriate monitoring and follow-up keeping in mind that, with time and counseling, most patients will understand that clinical MBL and CLL represent a continuum. © 2012 Informa UK, Ltd.
2012
clinical implications; monoclonal b-cell lymphocytosis; natural history
01 Pubblicazione su rivista::01a Articolo in rivista
Monoclonal B-cell lymphocytosis: A reappraisal of its clinical implications / Stefano, Molica; Mauro, Francesca Romana; Matteo, Molica; DEL GIUDICE, Ilaria; Foa, Roberto. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - 53:9(2012), pp. 1660-1665. [10.3109/10428194.2012.666542]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/469690
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact